Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GSK plc
  6. News
  7. Summary
    GSK   GB00BN7SWP63

GSK PLC

(GSK)
  Report
Real-time Estimate Cboe Europe  -  04:02:00 2023-01-27 am EST
1415.80 GBX   +0.75%
01/26UK earnings, trading statements calendar - next 7 days
AN
01/25UK earnings, trading statements calendar - next 7 days
AN
01/25GSK : Barclays reiterates its Neutral rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GSK CANADA SUBMITS RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CAN…

11/25/2022 | 07:12pm EST

GSK CANADA SUBMITS RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE CANDIDATE FOR REGULATORY REVIEW


ę Reuters 2022
All news about GSK PLC
01/26UK earnings, trading statements calendar - next 7 days
AN
01/25UK earnings, trading statements calendar - next 7 days
AN
01/25GSK : Barclays reiterates its Neutral rating
MD
01/24Pharma Stocks Weigh Down European Equities in Tuesday Trading
MT
01/24Europe's revenue growth expected to slow to a crawl in Q4
RE
01/24UK's FTSE 100 slips ahead of business activity data
RE
01/23Bayer Chairman Faces Criticism From Investor for Lack of Initiative, WirtschaftsWoche R..
DJ
01/19GSK : JP Morgan reaffirms its Sell rating
MD
01/18Factbox-Moderna data puts the spotlight on RSV vaccines under development
RE
01/18FTSE 100 Closes Down 0.3% as UK Inflation Puts Pressure on Pound
DJ
More news
Analyst Recommendations on GSK PLC
More recommendations
Financials
Sales 2022 29 102 M 35 977 M 35 977 M
Net income 2022 6 197 M 7 661 M 7 661 M
Net Debt 2022 14 605 M 18 055 M 18 055 M
P/E ratio 2022 8,90x
Yield 2022 4,34%
Capitalization 57 065 M 70 545 M 70 545 M
EV / Sales 2022 2,46x
EV / Sales 2023 2,41x
Nbr of Employees 90 096
Free-Float 93,7%
Chart GSK PLC
Duration : Period :
GSK plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GSK PLC
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Last Close Price 1 405,20 GBX
Average target price 1 694,98 GBX
Spread / Average Target 20,6%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Jon Ellis VP & Head-Technology Business Development
Tony Wood Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GSK PLC-2.25%70 545
JOHNSON & JOHNSON-4.04%441 560
ELI LILLY AND COMPANY-4.40%330 671
NOVO NORDISK A/S0.14%309 711
ROCHE HOLDING AG-0.52%277 411
MERCK & CO., INC.-3.68%270 958